KR102239725B1 - 디아자비시클로옥탄 유도체의 제조법과 그의 중간체 - Google Patents

디아자비시클로옥탄 유도체의 제조법과 그의 중간체 Download PDF

Info

Publication number
KR102239725B1
KR102239725B1 KR1020167009769A KR20167009769A KR102239725B1 KR 102239725 B1 KR102239725 B1 KR 102239725B1 KR 1020167009769 A KR1020167009769 A KR 1020167009769A KR 20167009769 A KR20167009769 A KR 20167009769A KR 102239725 B1 KR102239725 B1 KR 102239725B1
Authority
KR
South Korea
Prior art keywords
benzyloxy
tert
amino
compound represented
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020167009769A
Other languages
English (en)
Korean (ko)
Other versions
KR20160058851A (ko
Inventor
다카오 아베
다케시 후루우치
요시아키 사카마키
나카코 미츠하시
Original Assignee
메이지 세이카 파루마 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 메이지 세이카 파루마 가부시키가이샤 filed Critical 메이지 세이카 파루마 가부시키가이샤
Publication of KR20160058851A publication Critical patent/KR20160058851A/ko
Application granted granted Critical
Publication of KR102239725B1 publication Critical patent/KR102239725B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
KR1020167009769A 2013-09-24 2014-09-24 디아자비시클로옥탄 유도체의 제조법과 그의 중간체 Active KR102239725B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013197110 2013-09-24
JPJP-P-2013-197110 2013-09-24
PCT/JP2014/075203 WO2015046207A1 (ja) 2013-09-24 2014-09-24 ジアザビシクロオクタン誘導体の製造法とその中間体

Publications (2)

Publication Number Publication Date
KR20160058851A KR20160058851A (ko) 2016-05-25
KR102239725B1 true KR102239725B1 (ko) 2021-04-12

Family

ID=52743343

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020167009769A Active KR102239725B1 (ko) 2013-09-24 2014-09-24 디아자비시클로옥탄 유도체의 제조법과 그의 중간체

Country Status (22)

Country Link
US (2) US10000491B2 (enExample)
EP (1) EP3050883B1 (enExample)
JP (1) JP6453222B2 (enExample)
KR (1) KR102239725B1 (enExample)
CN (2) CN105555787B (enExample)
AR (5) AR097744A1 (enExample)
AU (1) AU2014324302B2 (enExample)
BR (1) BR112016006246B8 (enExample)
CA (1) CA2924953C (enExample)
DK (1) DK3050883T3 (enExample)
ES (1) ES2793201T3 (enExample)
HK (1) HK1244487A1 (enExample)
HU (1) HUE049027T2 (enExample)
IL (1) IL244740B (enExample)
MX (2) MX367578B (enExample)
MY (2) MY193210A (enExample)
NZ (1) NZ718009A (enExample)
RU (1) RU2719480C2 (enExample)
SG (1) SG11201602256UA (enExample)
TW (1) TWI644908B (enExample)
WO (1) WO2015046207A1 (enExample)
ZA (1) ZA201602053B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201605368UA (en) 2012-05-30 2016-08-30 Meiji Seika Pharma Co Ltd NOVEL β-LACTAMASE INHIBITOR AND PROCESS FOR PREPARING THE SAME
AU2014324302B2 (en) 2013-09-24 2018-02-15 Meiji Seika Pharma Co., Ltd. Production method for diazabicyclooctane derivative and intermediary body thereof
CN105612159A (zh) 2013-10-08 2016-05-25 明治制果药业株式会社 二氮杂二环辛烷衍生物的结晶及其制备方法
CA2969192C (en) 2014-12-05 2023-02-28 Meiji Seika Pharma Co., Ltd. A process for producing crystals of a diazabicylooctane derivative and a stable lyophilized composition thereof
CA2944306C (en) 2015-10-30 2023-11-14 The Toronto-Dominion Bank Validating encrypted data from a multi-layer token
US11216808B2 (en) 2015-11-04 2022-01-04 The Toronto-Dominion Bank Token-based system for excising data from databases
JP2020011901A (ja) * 2016-10-20 2020-01-23 協和キリン株式会社 ピロリジン化合物の製造方法
CN106699756B (zh) * 2016-12-30 2019-10-29 淄博鑫泉医药技术服务有限公司 β内酰胺酶抑制剂阿维巴坦的合成方法
US10682413B2 (en) 2017-09-27 2020-06-16 Fedora Pharmaceuticals Inc. Pharmaceutical forms of diazabicyclooctane derivatives and process for producing the same
US10584123B2 (en) 2017-09-27 2020-03-10 Fedora Pharmaceuticals Inc. Pharmaceutical forms of diazabicyclooctane derivatives and manufacturing method thereof
EP3687992A1 (en) 2017-09-27 2020-08-05 Meiji Seika Pharma Co., Ltd. Crystalline forms of diazabicyclooctane derivatives and production process thereof
CN109678856B (zh) * 2017-10-18 2020-09-25 新发药业有限公司 一种阿维巴坦中间体的制备方法
EP3714046A1 (en) 2017-11-23 2020-09-30 H. Hoffnabb-La Roche Ag Proline hydroxylases as well as uses, methods and products involving the same
WO2020018462A1 (en) 2018-07-16 2020-01-23 Brown University A chromogenic beta-lactamase substrate
JP7523354B2 (ja) * 2018-09-21 2024-07-26 株式会社エーピーアイ コーポレーション アミノ酸誘導体の製造方法
US12195755B2 (en) 2019-05-20 2025-01-14 Brown University Placental lipid bilayer for cell-free molecular interaction studies
US11751775B2 (en) 2019-08-30 2023-09-12 DePuy Synthes Products, Inc. Electrical device for monitoring, prevention, and treatment of implant infections
CN121021508A (zh) * 2025-10-29 2025-11-28 北京耀诚惠仁科技有限公司 β-内酰胺酶抑制剂中间体共晶或盐及其制备方法和应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012086241A1 (ja) 2010-12-22 2012-06-28 Meiji Seikaファルマ株式会社 光学活性なジアザビシクロオクタン誘導体およびその製造法
WO2012172368A1 (en) 2011-06-17 2012-12-20 Astrazeneca Ab Process for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5038509B1 (enExample) 1970-10-21 1975-12-10
JPS538509A (en) 1976-07-13 1978-01-26 Toshiba Corp Impedance matching system for data transmission circuit
JPS6019759B2 (ja) 1977-11-24 1985-05-17 イ−ライ・リリ−・アンド・カンパニ− 非経口投予用11115152139199東京都中央区京橋2丁目3番13号
GB1589317A (en) 1977-11-24 1981-05-13 Lilly Co Eli Freeze drying cephalothin sodium
JPS60255723A (ja) 1984-05-31 1985-12-17 Ono Pharmaceut Co Ltd メシル酸ガベキサートの結晶性凍結乾燥製剤及びその製造方法
JPH07117533B2 (ja) 1985-08-28 1995-12-18 株式会社生体科学研究所 トランスフエリンおよびその用途
US20030220521A1 (en) 1989-07-27 2003-11-27 G.D. Searle & Co. Renal-selective prodrugs for control of renal sympathetic nerve activity in the treatment of hypertension
TW264475B (enExample) 1991-09-20 1995-12-01 Takeda Pharm Industry Co Ltd
ES2127946T3 (es) * 1993-12-29 1999-05-01 Pfizer Antagonistas de neurocinina diazabiciclica.
US6111098A (en) 1994-05-02 2000-08-29 Shionogi & Co., Ltd. Crystal of pyrrolidylthiocarbapenem derivative, lyophilized preparation containing said crystal, and process for producing the same
JP2843444B2 (ja) 1994-05-02 1999-01-06 塩野義製薬株式会社 ピロリジルチオカルバペネム誘導体の結晶,該結晶を含む凍結乾燥製剤,およびその製造方法
FR2812635B1 (fr) 2000-08-01 2002-10-11 Aventis Pharma Sa Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens
FR2815420B1 (fr) 2000-10-16 2003-05-16 Cit Alcatel Compensation de la dispersion chromatique dans un systeme de transmission a fibre optique, et fibre de compensation
FR2825705B1 (fr) 2001-06-08 2005-05-20 Aventis Pharma Sa Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens
FR2835186B1 (fr) 2002-01-28 2006-10-20 Aventis Pharma Sa Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases
FR2921060B1 (fr) 2007-09-14 2012-06-15 Novexel Nouveau procede de preparation d'une piperidine disubsituee et nouveaux intermediaires
EP2231667B1 (en) 2008-01-18 2013-09-04 Merck Sharp & Dohme Corp. Beta-lactamase inhibitors
FR2930553B1 (fr) 2008-04-29 2010-05-21 Novexel Composes azabicycliques, leur preparation et leur utilisation comme medicaments, notamment inhibiteurs de beta-lactamases
FR2936798B1 (fr) 2008-10-03 2012-09-28 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens.
US20120053350A1 (en) 2009-04-30 2012-03-01 Ian Mangion Preparation of alkyl esters of n-protected oxo-azacycloalkylcarboxylic acids
FR2951171A1 (fr) * 2009-10-09 2011-04-15 Novexel Nouveau sel de sodium d'un compose azabicyclique sous forme enantiomere cristallisee et nouvelles formes polymorphes et pseudopolymorphes ainsi que leur preparation
JP2012122603A (ja) 2010-11-15 2012-06-28 Nifco Inc コネクタ装置
US8772490B2 (en) 2010-12-22 2014-07-08 Meiji Seika Pharma Co., Ltd. Optically active diazabicyclooctane derivatives and process for preparing the same
RU2636147C1 (ru) 2011-08-27 2017-11-21 Вокхардт Лимитед Производные 1,6-диазабицикло[3,2,1]октан-7-она и их применение при лечении бактериальных инфекционных болезней
BR112013032974A2 (pt) 2011-08-30 2016-09-06 Wockhardt Ltd "derivados de 1,6-diazabiciclo [3,2,1]-octan-7-ona, seus usos, e composições farmacêuticas".
MX349827B (es) 2011-09-13 2017-08-14 Wockhardt Ltd Compuestos que contienen nitrogeno y su uso.
US9505761B2 (en) 2011-12-02 2016-11-29 Fedora Pharmaceuticals Inc. Bicyclic compounds and their use as antibacterial agents and beta-lactamase inhibitors
US8796257B2 (en) 2011-12-02 2014-08-05 Naeja Pharmaceutical Inc. Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
SG10201605368UA (en) 2012-05-30 2016-08-30 Meiji Seika Pharma Co Ltd NOVEL β-LACTAMASE INHIBITOR AND PROCESS FOR PREPARING THE SAME
AU2014324302B2 (en) 2013-09-24 2018-02-15 Meiji Seika Pharma Co., Ltd. Production method for diazabicyclooctane derivative and intermediary body thereof
CN105612159A (zh) 2013-10-08 2016-05-25 明治制果药业株式会社 二氮杂二环辛烷衍生物的结晶及其制备方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012086241A1 (ja) 2010-12-22 2012-06-28 Meiji Seikaファルマ株式会社 光学活性なジアザビシクロオクタン誘導体およびその製造法
WO2012172368A1 (en) 2011-06-17 2012-12-20 Astrazeneca Ab Process for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof

Also Published As

Publication number Publication date
MX367578B (es) 2019-08-27
ES2793201T3 (es) 2020-11-13
AR131188A2 (es) 2025-02-26
AR131190A2 (es) 2025-02-26
JPWO2015046207A1 (ja) 2017-03-09
US10000491B2 (en) 2018-06-19
WO2015046207A1 (ja) 2015-04-02
TWI644908B (zh) 2018-12-21
MY193210A (en) 2022-09-26
EP3050883A4 (en) 2017-05-10
IL244740B (en) 2018-11-29
HK1244487A1 (zh) 2018-08-10
BR112016006246B8 (pt) 2021-10-05
RU2016115767A (ru) 2017-10-26
AU2014324302A1 (en) 2016-05-12
MX372585B (es) 2020-04-17
MY176278A (en) 2020-07-27
JP6453222B2 (ja) 2019-01-16
AR131189A2 (es) 2025-02-26
HK1219473A1 (zh) 2017-04-07
CN105555787A (zh) 2016-05-04
MX2016003867A (es) 2016-08-04
IL244740A0 (en) 2016-04-21
EP3050883A1 (en) 2016-08-03
CN105555787B (zh) 2017-08-08
BR112016006246A2 (enExample) 2017-08-22
US20160264573A1 (en) 2016-09-15
TW201546059A (zh) 2015-12-16
CA2924953C (en) 2021-12-07
CA2924953A1 (en) 2015-04-02
US20170283415A1 (en) 2017-10-05
ZA201602053B (en) 2019-06-26
CN107501264A (zh) 2017-12-22
HUE049027T2 (hu) 2020-08-28
AR097744A1 (es) 2016-04-13
SG11201602256UA (en) 2016-04-28
RU2719480C2 (ru) 2020-04-17
AR131186A2 (es) 2025-02-26
AU2014324302B2 (en) 2018-02-15
KR20160058851A (ko) 2016-05-25
NZ718009A (en) 2018-03-23
DK3050883T3 (da) 2020-05-25
RU2016115767A3 (enExample) 2018-06-29
US10000492B2 (en) 2018-06-19
BR112016006246B1 (pt) 2021-09-08
EP3050883B1 (en) 2020-04-22

Similar Documents

Publication Publication Date Title
KR102239725B1 (ko) 디아자비시클로옥탄 유도체의 제조법과 그의 중간체
KR102108590B1 (ko) 신규 β-락타마아제 저해제 및 그의 제조법
KR102487297B1 (ko) 디아자비시클로옥탄 유도체의 결정과 그의 제조법
DE69005286T2 (de) Peptide mit tachykininantagonistischer Aktivität, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate.
JP2000516252A (ja) 1,4―複素環式メタロプロテアーゼ阻害剤
SA96160637B1 (ar) مشتقات aroy1- piperidine
KR20100033541A (ko) 멜라노코르틴-4 수용체 모듈레이터로서의 치환된 헤테로아릴피페리딘 유도체
EA030032B1 (ru) 5,6-дизамещенные пиридин-2-карбоксамиды в качестве агонистов каннабиноидных рецепторов
KR19990063850A (ko) Nmda 길항제로서의 테트라히드로퀴놀린
US20040024000A1 (en) Dihydropyrimidine derivatives as cysteine protease inhibitors
JP2003533521A (ja) ヒドロキサム酸誘導体
CA2347506C (en) Quinazolinone derivatives
PT1641787E (pt) Dicetopiperazinas substituídas e sua utilização como antagonistas da oxitocina
US6503897B1 (en) Antibacterial agents
JP4486823B2 (ja) ヒドロキサム酸誘導体
WO2007148774A1 (ja) 環状アミン化合物
CN100422170C (zh) 喹诺酮羧酸衍生物的制备方法
KR20010074420A (ko) 뉴로키닌 길항제로서의 치환된 옥심
HK1219473B (en) Production method for diazabicyclooctane derivative and intermediary body thereof
JP3233276B2 (ja) カッパアゴニストとしてのヒドラジド化合物
LT3073B (en) N-(hydroxyethyl)butanediamide derivatives
US20080293721A1 (en) Arylthioacetamide carboxylate derivatives as fkbp inhibitors for the treatment of neurological diseases
JP2000229998A (ja) 新規化合物
JPH01149763A (ja) メルカプトプロパンアミドの誘導体
EP0136266A2 (de) 7beta-Acylamido-3-cephem-4-carbonsäureester, Verfahren zu ihrer Herstellung, pharmazeutische Präparate, welche diese Verbindungen enthalten, und Verwendung von letzteren

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20160414

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20190920

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20201211

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20210326

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20210407

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20210407

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20240319

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20250317

Start annual number: 5

End annual number: 5